LIONS (PLK4 Inhibitor in Advanced Solid Tumors)
NCT06232408
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
29
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor decided to terminate study early
Conditions
Advanced Solid Tumor
Interventions
DRUG:
RP-1664
Sponsor
Repare Therapeutics